| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/15/2002 | CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 05/15/2002 | CN1349503A Renin ihibitors |
| 05/15/2002 | CN1349500A 3,3-substituted indoline derivatives |
| 05/15/2002 | CN1349499A Thio-oxindole derivatives |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349411A Compositions containing benzimidazolones and progestogens |
| 05/15/2002 | CN1349408A Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| 05/15/2002 | CN1349406A Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 05/15/2002 | CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof |
| 05/15/2002 | CN1348777A Method of feeding ox with bezoar essence to form natural bezoar |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084748C Aminomethyl-2,3,8,9-terahydro-7H-1,4,-dioxino [2,3-e]-indol-8-ones and derivatives |
| 05/15/2002 | CN1084747C Azolobenzazepine derivs, as neurological active agents |
| 05/15/2002 | CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/15/2002 | CN1084620C Medicine for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 05/15/2002 | CN1084619C Process for preparing medicine composition |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/15/2002 | CN1084617C Combination treatment for osteoporosis |
| 05/15/2002 | CN1084616C Coatings for tablet of paracetamol and domperidone |
| 05/14/2002 | US6388109 Hormone replacement therapy |
| 05/14/2002 | US6388092 Antitumor agent |
| 05/14/2002 | US6388071 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents |
| 05/14/2002 | US6387953 Inhibition of TNF-(α)-initiated neutrophil response |
| 05/14/2002 | US6387941 Antiserotonine agents |
| 05/14/2002 | US6387937 Indole derivatives |
| 05/14/2002 | US6387932 Somatostatin agonists |
| 05/14/2002 | US6387927 Water solubility |
| 05/14/2002 | US6387926 Inhibitors of farnesyl protein transferase |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/14/2002 | US6387920 Isoxazole compounds; for treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, alzheimer's disease |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387911 Pyrazinone thrombin inhibitors |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387897 Preferentially substituted calcium channel blockers |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387891 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury |
| 05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387638 Heregulin variants |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387406 Copolymer compositions for oral delivery |
| 05/14/2002 | US6387403 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 05/14/2002 | US6387389 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387364 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/14/2002 | CA2354832C Chlorella preparations exhibiting immunomodulating properties |
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/14/2002 | CA2260898C Phosphinate based inhibitors of matrix metalloproteases |
| 05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 05/14/2002 | CA2249666C Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 05/14/2002 | CA2247105C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic di seases |
| 05/14/2002 | CA2214829C Methods and compositions for in-vivo detection of oral cancers and precancerous conditions |
| 05/14/2002 | CA2202030C Method for reducing unwanted cellular adhesions |
| 05/14/2002 | CA2179540C Accelerated release composition containing bromocriptine |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2105071C Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| 05/14/2002 | CA2105067C Indan derivative and thromboxane antagonist containing the same |
| 05/14/2002 | CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes |
| 05/14/2002 | CA2034849C Equine aerosol drug delivery method and apparatus |
| 05/14/2002 | CA2010542C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | WO2002036765A1 Novel protein and dna thereof |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036751A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036734A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036605A2 Estrone-derivatives having cytoprotective activity |
| 05/10/2002 | WO2002036599A1 Thieno[2,3-c]isoquinolines for use as inhibitors of parp |
| 05/10/2002 | WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036592A1 Remedies for arachidonic acid-induced skin diseases |
| 05/10/2002 | WO2002036590A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | WO2002036589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 05/10/2002 | WO2002036587A2 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| 05/10/2002 | WO2002036576A1 Phthalazinone derivatives |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036571A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | WO2002036570A1 4-substituted quinolines as antitumor agents |
| 05/10/2002 | WO2002036568A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036565A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/10/2002 | WO2002036564A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors |
| 05/10/2002 | WO2002036563A1 Crystalline forms of fluvastatin sodium |
| 05/10/2002 | WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036556A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |